ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions
View by Date

Monday, November 9, 2015

9:00AM-11:00AM
Abstract Number: 1124
Bruton’s Tyrosine Kinase Levels Are Increased in B Cells from Patients with Primary Sjögren’s Syndrome
B cell Biology and Targets in Rheumatolid Arthritis and other Autoimmune Disease Poster
9:00AM-11:00AM
Abstract Number: 1284
Burden of Illness Associated with Non-Radiographic Axial Spondyloarthritis: A European Real World Database Analysis from the Clinical and Healthcare System Perspective
Health Services Research Poster II (ACR): Healthcare Access, Patterns of Medication Use and Workforce Considerations
9:00AM-11:00AM
Abstract Number: 1290
Burden of Rheumatoid Arthritis in the US Elderly Population: Comorbidities, Healthcare Resource Utilization, and Cost
Health Services Research Poster II (ACR): Healthcare Access, Patterns of Medication Use and Workforce Considerations
9:00AM-11:00AM
Abstract Number: 1894
Calcium Channel Blockers Are More Effective in the Treatment of Primary Raynaud’s Phenomenon Compared to Secondary: A Meta-Analyis
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II
9:00AM-11:00AM
Abstract Number: 1299
Can Bone Marrow Lesions be Scored More Reliably and Responsively in Knee Osteoarthritis Using a Web-Based Overlay System (KIMRISS) Than By Standard MRI Osteoarthritis Knee Scoring (MOAKS)?  Data from the Osteoarthritis Initiative and a Prospective Trial of Adaluminab Therapy
Imaging of Rheumatic Diseases Poster II: X-ray, MRI, PET and CT
9:00AM-11:00AM
Abstract Number: 1490
Can Patients Forget Their Artificial Joint after Arthroplasty?
Quality Measures and Quality of Care Poster Session (ARHP): Clinical Practice/Patient Care
9:00AM-11:00AM
Abstract Number: 1719
Can Structural Progression on MRI of Sacroiliac Joints in Patients with Spondyloarthritis be Reliably Detected and What Type of Calibration Is Necessary to Achieve This?
Spondylarthropathies and Psoriatic Arthritis - Comorbidities and Treatment Poster II
9:00AM-11:00AM
Abstract Number: 1969
Can We Predict the Relapse of Giant Cell Arteritis?
Vasculitis Poster II
9:00AM-11:00AM
Abstract Number: 1581
Cardiac Involvement in Patients with Amyloid a Amyloidosis Due to Rheumatoid Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster II
9:00AM-11:00AM
Abstract Number: 1568
Cardiac Morphology and Function in Patients with Acute Coronary Syndrome Complicated with Rheumatoid Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster II
9:00AM-11:00AM
Abstract Number: 1972
Cardiovascular and Cerebrovascular Disease and Social Deprivation in Patients with Giant Cell Arteritis
Vasculitis Poster II
9:00AM-11:00AM
Abstract Number: 1604
Cardiovascular Disease in a Large Incident Cohort of Early Inflammatory Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster II
9:00AM-11:00AM
Abstract Number: 1540
Cardiovascular Risk Management in Rheumatoid Arthritis Patients
Rheumatoid Arthritis - Clinical Aspects Poster II
9:00AM-11:00AM
Abstract Number: 1505
Carotid Artery Atherosclerosis in Patients with Active Rheumatoid Arthritis: Predictors of Plaque Occurrence and Progression over 24 Weeks
Rheumatoid Arthritis - Clinical Aspects Poster II
9:00AM-11:00AM
Abstract Number: 1876
Caveolin 1 Gene Variants May Effect Disease Progression in Systemic Sclerosis Related Interstitial Lung Disease
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II
  • «Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 72
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology